DG HEALTH CLEARLAX - polyethylene glycol 3350 powder, for solution 
Dolgencorp Inc

----------

Dolgencorp, LLC ClearLax® Drug Facts

Active ingredient (in each dose)

Polyethylene Glycol 3350, 17 g (cap filled to line)

Purpose

Laxative

Uses

Warnings

Allergy alert: Do not use if you are allergic to polyethylene glycol

Do not use

if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

Ask a doctor or pharmacist before use if you are

taking a prescription drug

When using this product

you may have loose, watery, more frequent stools

Stop use and ask a doctor if

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

none

Questions?

1-888-309-9030

Principal Display Panel

Compare to active ingredient of MiraLAX®

ClearLax®

Polyethylene Glycol 3350

Powder for Solution, Laxative

Original Prescription Strength

Relieves Occasional Constipation

Softens Stool

# Once-Daily Doses

ClearLax(R) Front Label

ClearLax(R) Front Label

ClearLax(R) Back Label

ClearLax(R) Back Label


DG HEALTH CLEARLAX 
polyethylene glycol 3350   powder, for solution
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)55910-306
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 3350 (POLYETHYLENE GLYCOL 3350) POLYETHYLENE GLYCOL 335017 g  in 17 g
Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found
Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
155910-306-01119 g In 1 BOTTLENone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09068510/07/2009

Labeler - Dolgencorp Inc (068331990)
Revised: 10/2009Dolgencorp Inc